Skip to main content
SpringerLink
Log in

Ciprofloxacin ototoxicity

  • Drug News
  • Published:
Indian Journal of Otolaryngology and Head and Neck Surgery Aims and scope Submit manuscript

Abstract

A case of bilateral moderate sensori-neural hearing loss due to oral administration of ciprofloxacin is reported. To our best of knowledge so far ciprofloxacin associated hearing loss has not been reported. The hearing loss recovered gradually in a period of 4–5 weeks following withdrawal of the drug. Traditionally, the known side effects of ciprofloxacin are not serious in nature and reversible which is true of the hearing loss in the present case. Awareness of this side effect is of paramount importance and further reports are awaited in this regard.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arcieri, G.M., Becker, N., Esposito, B., Griffith, E., Heyd, A., Neumann, C., O’Brien, B., Schacht, P., (1989): Safety of Intravenous Ciprofloxacin. The American Journal of Medicine, 87 (Suppl 5A) 92S-97S.

    Article  PubMed  CAS  Google Scholar 

  2. Brownlee, R.E., Hulka, G.F., Prazma, J., Pillsbury III, H.C., (1992): Ciprofloxacin use as a topical otic preparation. Archives of Otolaryngology-Head and Neck Surgery 118; 392–396.

    PubMed  CAS  Google Scholar 

  3. Chodosh, S., Tuck, J., Stottmeier, K.D., Pizzuto, D. (1989): Comparison of Ciprofloxacin with Ampicillin in Acute Infectious Exacerbations of Chronic Bronchitis. A double blind crossover study. The American Journal of Medicine 87 (Suppl. 5A) 107S-112S.

    Article  PubMed  CAS  Google Scholar 

  4. Levenson, M.J., Parisier, S.C., Dolitsky, J., Bindra, G., (1991): Ciprofloxacin: Drug of choice in the treatrment of Malignant External Otitis. Laryngoscope, 101; 821–824.

    Article  PubMed  CAS  Google Scholar 

  5. Nomura, M., Yamada, M., Yamamura, H., Kazimura, T., Takayama, S., (1992): Ophthalmotoxicity and Ototoxicity of the new quinolone antibacterial agent Levofloxacin in Long Evans rate. Journal of Laryngology & Otology (Abstract selection) 106: 937.

    Google Scholar 

  6. Schacht, P., Arcieri, G., Hullmann, R., (1989): Safety of Oral Ciprofloxacin. An update based on clinical trial results. The American Journal of Medicine, 87 (Suppl. 5A) 98S-102S.

    Article  PubMed  CAS  Google Scholar 

  7. Schluter, G., (1989): Ciprofloxacin: Toxicologic Evaluation of Additional Safety Data. The American Journal of Medicine 87 (Suppl. 5A) 37S-39S.

    Article  PubMed  CAS  Google Scholar 

  8. Wise, R., Donovan, I.A., (1987): Tissue penetration and metabolism of Ciprofloxacin. The American Journal of Medicine, 82 (Suppl. 4A) 103–107.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of ENT, JLN Hospital & Research Centre Bhilai Steel Plant, 490006, Bhilai (MP)

    S. Md Iqbal, J. G. Murthy & P. K. Banerjee

  2. Dept. of Medicine, JLN Hospital & Research Centre Bhilai Steel Plant, 490006, Bhilai (MP)

    K. A. Vishwanathan

Authors
  1. S. Md Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. G. Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. K. Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. A. Vishwanathan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iqbal, S.M., Murthy, J.G., Banerjee, P.K. et al. Ciprofloxacin ototoxicity. IJO & HNS 48, 168–170 (1996). https://doi.org/10.1007/BF03048074

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03048074

Search

Navigation